CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsAltman Z-Score 6.17: safe zone
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
3.02%
Annual Rate
CNY 0.50Paid annual
Payout Ratio
59.5%Sustainable
Payback Period
33.0 yr
Last Ex-Dividend
Jun 2, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
7.85BCNY1.17B · vs all stocks (USD)
Trailing P/E
19.48xRevenue (TTM)
3.58BCNY534.69M · vs all stocks (USD)
Profit Margin
10.83%Beta
0.1060xvs all stocks
52-Week Change
-25.86%vs all stocks
Market Capitalization
7.85BCNY1.17B · vs all stocks (USD)
Enterprise Value
5.36BCNY801.13M · vs all stocks (USD)
Trailing P/E
19.48xPrice to Sales (TTM)
2.19xPrice to Book (MRQ)
2.05xEnterprise to Revenue
1.50xEnterprise to EBITDA
10.38xGross Margin
58.81%Profit Margin
10.83%Operating Margin
8.94%Return on Assets (TTM)
5.07%Return on Equity (TTM)
10.65%Revenue (TTM)
3.58BCNY534.69M · vs all stocks (USD)
Revenue per Share (TTM)
7.73CNYUpdated Sep 22, 2026Quarterly Revenue Growth
11.90%Gross Profit (TTM)
2.22BCNY331.52M · vs all stocks (USD)
EBITDA (TTM)
673.34MCNY100.55M · vs all stocks (USD)
Net Income (TTM)
387.69MCNY57.89M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-33.80%Operating Cash Flow (TTM)
399.66MCNY59.68M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
105.24MCNY15.72M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.5000CNYUpdated Sep 22, 2026Trailing Annual Dividend Yield
3.02%vs all stocks
Payout Ratio
59.52%Minority Interest (Equity)
13.42MCNYFY2025 · Dec 31, 2025Revenue
3.50BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
1.21BCNYFY2025 · Dec 31, 2025Gross Profit
2.30BCNYFY2025 · Dec 31, 2025Operating Income
523.66MCNY78.20M · vs all stocks (USD)
Pre-tax Income
523.34MCNYFY2025 · Dec 31, 2025Income Tax Expense
52.08MCNYFY2025 · Dec 31, 2025Net Income
471.26MCNYFY2025 · Dec 31, 2025EBIT
524.92MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
673.34MCNYFY2025 · Dec 31, 2025Research & Development
403.42MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
987.79MCNYFY2025 · Dec 31, 2025Other Operating Expenses
40.87MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
13.58MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
1.58MCNYFY2025 · Dec 31, 2025EPS (Basic)
1.00CNYFY2025 · Dec 31, 2025EPS (Diluted)
1.00CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
469.36MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
469.36MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
471.26MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-1.90MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
277.31MCNYFY2025 · Dec 31, 2025Free Cash Flow
-119.21MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
634.05MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
471.26MCNYFY2025 · Dec 31, 2025Other Non-cash Items
10.16MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-127.89MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-76.23MCNYFY2025 · Dec 31, 2025Capital Expenditures
-396.52MCNYFY2025 · Dec 31, 2025Sale of Investments
18.82MCNYFY2025 · Dec 31, 2025Other Investing Activity
230.20MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-147.50MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-40.00MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-234.24MCNYFY2025 · Dec 31, 2025Other Financing Charges
-18.83MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-293.07MCNYFY2025 · Dec 31, 2025Shares Outstanding
480.00MSharesUpdated Sep 22, 2026Float Shares
115.53MSharesUpdated Sep 22, 2026% Held by Insiders
73.80%vs all stocks
% Held by Institutions
5.56%vs all stocks
Total Cash (MRQ)
2.04BCNY305.14M · vs all stocks (USD)
Total Cash per Share (MRQ)
4.37CNYUpdated Sep 22, 2026Total Debt (MRQ)
17.63MCNY2.63M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0047xCurrent Ratio (MRQ)
3.03xBook Value per Share (MRQ)
7.97CNYUpdated Sep 22, 2026Total Assets
4.92BCNY735.29M · vs all stocks (USD)
Total Current Assets
3.05BCNYFY2025 · Dec 31, 2025Total Liabilities
1.13BCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.87BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
79.85MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.05BCNYFY2025 · Dec 31, 2025Cash
634.05MCNYFY2025 · Dec 31, 2025Cash Equivalents
307.00KCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
634.36MCNYFY2025 · Dec 31, 2025Other Short-term Investments
1.43BCNYFY2025 · Dec 31, 2025Accounts Receivable
412.37MCNYFY2025 · Dec 31, 2025Inventory
412.66MCNYFY2025 · Dec 31, 2025Accounts Payable
258.49MCNYFY2025 · Dec 31, 2025Short-term Debt
16.76MCNYFY2025 · Dec 31, 2025Other Current Liabilities
27.53MCNYFY2025 · Dec 31, 2025Long-term Debt
9.00MCNYFY2025 · Dec 31, 2025Common Stock (Book)
480.00MCNYFY2025 · Dec 31, 2025Retained Earnings
1.58BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
3.79BCNY566.37M · vs all stocks (USD)
Treasury Stock
176.19MCNYFY2025 · Dec 31, 202552-Week Low
15.28CNYUpdated Sep 22, 202652-Week High
30.80CNYUpdated Sep 22, 202652-Week Change
-25.86%vs all stocks
Beta
0.1060xvs all stocks
50-Day MA
16.89CNYUpdated Sep 22, 2026200-Day MA
21.09CNYUpdated Sep 22, 2026Avg 10-Day Volume
2.17MSharesUpdated Sep 22, 2026Avg 30-Day Volume
4.16MSharesUpdated Sep 22, 2026Diluted EPS (TTM)
0.8400CNYUpdated Sep 22, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Diagnostic
Debt Falling While Share Count Rises
Debt has fallen for four years while the share count rose over eight.
Reads
How does this company use capital?
Cash Backing With Revenue And Income Streaks
Revenue has risen in each of three years, profit in all three, and it holds more cash than debt.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 6.17: safe zoneNotable
Altman Z-Score: 6.17
High earnings qualityNotable
Earnings Quality Score: 0.51
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Hunan Warrants Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Avanos Medical Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Glass House Brands Inc.
Tier 1ProductionApproval-Gated PipelineFlowRule
Innovita Biological Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Sanofi Consumer Healthcare Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Replimune Group Inc.
Tier 1ProductionApproval-Gated PipelineRule
Tianjin Ringpu Bio-Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Beta Bionics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Harbin Gloria Pharmaceuticals Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Chongqing Taiji Industry Group Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Suzhou Sepax Technologies Inc.
2 interpretationsDebt Falling While Share Count RisesCash Backing With Revenue And Income Streaks
China Haisum Engineering Co., Ltd.
2 interpretationsDebt Falling While Share Count RisesCash Backing With Revenue And Income Streaks
Clear Secure Inc.
2 interpretationsDebt Falling While Share Count RisesCash Backing With Revenue And Income Streaks